imgimg
imgimg
img
img
imgimg
首頁
公共政策研究院
關於公共政策研究院
研究領域
img
精選內容
最新消息
研究刊物資料庫
img
活動回顧
img
中國文化研究院
香港地方志中心
活動資​​訊
媒體中心
關於我們
關於團結香港基金
img
惠澤機構/人士
img
管治架構
團結香港基金
img
中國文化研究院
img
香港地方志中心
img
顧問成員
img
管理層
法律及審計事務
年報
加入我們
聯絡我們
立即捐款
imgimgimgimgimgimgimg
Banner
最新動態

OHKF Deputy Research Director Victor Kwok Invited as Moderator for Roundtable Discussion on Advancing Innovative Medicines

2026年5月21日 (週四)

Victor Kwok, Deputy Research Director of Our Hong Kong Foundation (OHKF), was invited to attend and moderate the “Roundtable Discussion on Advancing Innovative Medicines,” co-organised by the Cancer Patient Alliance and 長期病患者關注醫療改革聯席 on 2 May.

Guests of the roundtable discussion included Assistant Director of Health (Preparatory Office for Centre for Medical Products Regulation) of Department of Health Chan Sze-Tao, Lot, Director (Cluster Services) of the Hospital Authority Dr Wong Yiu-chung; Member of the Legislative Council Dr Hon Chan Han-pan, BBS, JP; academic experts; and representatives from pharmaceutical companies.

The meeting focused on Hong Kong's performance in developing healthcare innovation and recommendations for further improvements to the current mechanisms for approving and registering innovative drugs, as well as strengthening support for local clinical research and drug development.


最後更新於 2026年7月15日 (週三)

Victor Kwok, Deputy Research Director of Our Hong Kong Foundation (OHKF), was invited to attend and moderate the “Roundtable Discussion on Advancing Innovative Medicines,” co-organised by the Cancer Patient Alliance and 長期病患者關注醫療改革聯席 on 2 May.

Guests of the roundtable discussion included Assistant Director of Health (Preparatory Office for Centre for Medical Products Regulation) of Department of Health Chan Sze-Tao, Lot, Director (Cluster Services) of the Hospital Authority Dr Wong Yiu-chung; Member of the Legislative Council Dr Hon Chan Han-pan, BBS, JP; academic experts; and representatives from pharmaceutical companies.

The meeting focused on Hong Kong's performance in developing healthcare innovation and recommendations for further improvements to the current mechanisms for approving and registering innovative drugs, as well as strengthening support for local clinical research and drug development.

最後更新於 2026年7月15日 (週三)
支持我們
立即捐款
聯絡我們
img
香港中環干諾道中88號南豐大廈19樓
img
+852 2603 3001
關注我們
imgimgimgimg
imgimgimg
ESG Care Organization
© 團結香港基金有限公司版權所有
支持我們
立即捐款
聯絡我們
香港中環干諾道中88號南豐大廈19樓
關注我們
imgimgimgimg
imgimgimg
ESG

© 團結香港基金有限公司版權所有